DELIVERY ORDER
Active75N93026F00002
Department of Health and Human Services › National Institutes of Health › NATIONAL INSTITUTES OF HEALTH NIAID
$2.6M
obligated · signed 2 weeks ago
PROTOTYPE PEDIATRIC ORAL DISSOLVING FILMS FOR THE PREVENTION OF TUBERCULOSIS
Performance timeline
Start
Sep 30, 2026
End
Sep 29, 2028
with all options
Loading status
Estimated start: Sep 29, 2027
ADVANCED BIOSCIENCE LABORATORIES, INC.
Contract 75N93026F00002
UEI
MK4QC9EKZXG8
Parent Company
COMPAGNIE MERIEUX ALLIANCE
Capabilities & Certifications
Headquarters Location
Congressional District: 08
Current Obligation
$2,559,631
Base + Exercised Options
$2,559,631
Total Ceiling Value
$2,559,631
Contract Type
COST PLUS FIXED FEE
Multi-Year Contract
NO
NAICS
RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)
PSC
HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH
Place of Performance
Congressional District: 08
Awarding Agency
Top-tier agency
National Institutes of Health
Sub-tier agency
NATIONAL INSTITUTES OF HEALTH NIAID
Office
Funding Agency
Top-tier agency
National Institutes of Health
Sub-tier agency
NATIONAL INSTITUTES OF HEALTH NIAID
Office
Contract Vehicle
75N93023D00001
IDCDepartment of Health and Human Services
Award type: MULTIPLE AWARD
Solicitation procedures, competition exceptions, labor standards and account totals.